Scott N Gettinger

Author PubWeight™ 68.26^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.	N Engl J Med	2012	52.99
2	Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.	N Engl J Med	2015	12.54
3	Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial.	J Clin Oncol	2012	1.84
4	Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing.	Cancer Res	2012	1.39
5	SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer.	Oncoimmunology	2013	1.02
6	Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hope.	Curr Opin Oncol	2008	0.96
7	A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer.	Clin Cancer Res	2013	0.93
8	Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assay.	Cancer	2011	0.90
9	Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer.	Clin Cancer Res	2010	0.90
10	Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.	Cancer Cytopathol	2013	0.85
11	Management of patients with advanced non-small cell lung cancer: current and emerging options.	Drugs	2010	0.80
12	Late recurrence of basaloid carcinoma initially treated as a small cell lung cancer.	J Thorac Dis	2013	0.75
13	Targeted therapy for thyroid cancer: An updated review of investigational agents.	Curr Opin Investig Drugs	2010	0.75